205 related articles for article (PubMed ID: 19359522)
21. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
22. N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients.
Radomska-Leśniewska DM; Skopińska-Rózewska E; Jankowska-Steifer E; Sobiecka M; Sadowska AM; Hevelke A; Malejczyk J
Pharmacol Rep; 2010; 62(1):131-8. PubMed ID: 20360623
[TBL] [Abstract][Full Text] [Related]
23. Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases.
Lenz AG; Hinze-Heyn H; Schneider A; Behr J; Häussinger K; Heindi S; Stanzel F; Maier KL
Respir Med; 2004 Aug; 98(8):737-45. PubMed ID: 15303638
[TBL] [Abstract][Full Text] [Related]
24. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.
Oltmanns U; Schmidt B; Hoernig S; Witt C; John M
Exp Lung Res; 2003 Jul; 29(5):315-28. PubMed ID: 12746045
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis.
Ji J; Zheng S; Liu Y; Xie T; Zhu X; Nie Y; Shen Y; Han X
J Transl Med; 2023 Sep; 21(1):640. PubMed ID: 37726818
[TBL] [Abstract][Full Text] [Related]
26. Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles.
Meyer KC; Powers C; Rosenthal N; Auerbach R
Am Rev Respir Dis; 1993 Nov; 148(5):1325-34. PubMed ID: 8239171
[TBL] [Abstract][Full Text] [Related]
27. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations.
Vassallo R; Jensen EA; Colby TV; Ryu JH; Douglas WW; Hartman TE; Limper AH
Chest; 2003 Oct; 124(4):1199-205. PubMed ID: 14555547
[TBL] [Abstract][Full Text] [Related]
28. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
Kopiński P
Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis.
Ishioka S; Saito T; Hiyama K; Haruta Y; Maeda A; Hozawa S; Inamizu T; Yamakido M
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Sep; 13(2):139-45. PubMed ID: 8893383
[TBL] [Abstract][Full Text] [Related]
30. Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis.
Landi C; Bargagli E; Bianchi L; Gagliardi A; Carleo A; Bennett D; Perari MG; Armini A; Prasse A; Rottoli P; Bini L
J Proteomics; 2013 May; 83():60-75. PubMed ID: 23528693
[TBL] [Abstract][Full Text] [Related]
31. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis.
Abbott GF; Rosado-de-Christenson ML; Franks TJ; Frazier AA; Galvin JR
Radiographics; 2004; 24(3):821-41. PubMed ID: 15143231
[TBL] [Abstract][Full Text] [Related]
32. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
Prasse A; Pechkovsky DV; Toews GB; Jungraithmayr W; Kollert F; Goldmann T; Vollmer E; Müller-Quernheim J; Zissel G
Am J Respir Crit Care Med; 2006 Apr; 173(7):781-92. PubMed ID: 16415274
[TBL] [Abstract][Full Text] [Related]
33. Adult pulmonary Langerhans' cell histiocytosis.
Tazi A
Eur Respir J; 2006 Jun; 27(6):1272-85. PubMed ID: 16772390
[TBL] [Abstract][Full Text] [Related]
34. Diffuse lung diseases in cigarette smokers.
Vassallo R
Semin Respir Crit Care Med; 2012 Oct; 33(5):533-42. PubMed ID: 23001806
[TBL] [Abstract][Full Text] [Related]
35. Lipocortin I gene expression is higher in blood monocytes than in BAL fluid macrophages in patients with pulmonary sarcoidosis.
Mikuniya T; Nagai S; Morita K; Mio T; Satake N; Izumi T
Sarcoidosis Vasc Diffuse Lung Dis; 1998 Mar; 15(1):38-43. PubMed ID: 9572000
[TBL] [Abstract][Full Text] [Related]
36. Increased endothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis.
Terashita K; Kato S; Sata M; Inoue S; Nakamura H; Tomoike H
Respirology; 2006 Mar; 11(2):145-51. PubMed ID: 16548898
[TBL] [Abstract][Full Text] [Related]
37. Smoking-related interstitial lung diseases: radiologic-pathologic correlation.
Hidalgo A; Franquet T; Giménez A; Bordes R; Pineda R; Madrid M
Eur Radiol; 2006 Nov; 16(11):2463-70. PubMed ID: 16865368
[TBL] [Abstract][Full Text] [Related]
38. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
[TBL] [Abstract][Full Text] [Related]
39. [Measurement of total glutathione concentration in bronchoalveolar lavage recovered from the patients with diffuse interstitial lung disease].
He QY; Ishii Y; Kitamura S
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Feb; 17(1):24-6, 61. PubMed ID: 8082213
[TBL] [Abstract][Full Text] [Related]
40. Expression of insulin-like growth factor-I (IGF-I) in alveolar macrophages and lymphocytes obtained by bronchoalveolar lavage (BAL) in interstitial lung diseases (ILD). Assessment of IGF-I as a potential local mitogen and antiapoptotic cytokine.
Kopiński P; Sładek K; Szczeklik J; Soja J; Szlubowski A; Balicka-Slusarczyk B; Lackowska B; Plato M; Szpechciński A
Folia Histochem Cytobiol; 2006; 44(4):249-58. PubMed ID: 17219718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
